Key Drugs to Watch in Oncology, Hematology, and Neurology for 2025

Each year, dozens of new drugs are launched and enter the market, offering countless patients new therapeutic options for a multitude of common diseases and conditions, such as in hemophilia management, oncology, or treatment of neurological conditions. In 2025, multiple drugs are poised to significantly transform their indicated disease states in the coming year and beyond.¹